| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Aug 16, 2022 | Inhibikase Therapeutics, Inc. | CEO | Buy | 55.0 | +5,000 | 0.09% | ✗ | $4K |
| May 27, 2022 | May 31, 2022 | Inhibikase Therapeutics, Inc. | CEO | Buy | 55.0 | +5,000 | 0.09% | ✗ | $4.9K |
| May 20, 2022 | May 23, 2022 | Inhibikase Therapeutics, Inc. | CEO | Buy | 55.0 | +10,000 | 0.19% | ✗ | $6K |
| Nov 17, 2021 | Nov 19, 2021 | Inhibikase Therapeutics, Inc. | CEO | Buy | 61.3 | +23,589 | 0.44% | ✗ | $46.6K |
| May 14, 2021 | May 18, 2021 | Inhibikase Therapeutics, Inc. | CEO | Sell | 40.0 | -16,918 | -0.32% | ✗ | $77.7K |